Alaunos Therapeutics (TCRT) FCF Margin Growth (3y) (2014 - 2025)
Alaunos Therapeutics (TCRT) FCF Margin Growth (3y) (2014 - 2025) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
FCF Margin Growth (3y) (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
- |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
- |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
10,029.00 |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
- |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
- |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
723.00 |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
- |
| 10 |
Alaunos Therapeutics |
4.31 Mn |
3.95 Mn |
- |
- |
| Date | Value |
|---|
| Dec 31, 2025 |
4.74 Mn |
| Dec 31, 2024 |
75.95 Mn |
| Mar 31, 2018 |
-950,831.00 |
| Dec 31, 2017 |
212,448.00 |
| Sep 30, 2017 |
87,188.00 |
| Jun 30, 2017 |
289,230.00 |
| Mar 31, 2017 |
341,159.00 |
| Dec 31, 2016 |
370,583.00 |
| Sep 30, 2016 |
685,582.00 |
| Jun 30, 2016 |
746,689.00 |
| Mar 31, 2016 |
835,392.00 |
| Dec 31, 2015 |
952,800.00 |
| Sep 30, 2015 |
995,941.00 |
| Jun 30, 2015 |
455,790.00 |
| Mar 31, 2015 |
942,832.00 |
| Dec 31, 2014 |
414,706.00 |
| Sep 30, 2014 |
408,280.00 |
| Jun 30, 2014 |
-87,250.00 |
| Mar 31, 2014 |
820,036.00 |
